Form D · Other Health Care

SonderMind Inc.

Denver, CO · CIK 0001726194

Offering snapshot reported Oct 5, 2021 · SEC filing

Reported sold
$242M
Offering amount: $242M
Investors reported
23
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 27, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 5, 2021Initial$241,549,903No comparison23SEC filing
Apr 7, 2020Initial$26,999,991No comparison12SEC filing
Apr 23, 2019Initial$2,999,997No comparison22SEC filing
Oct 15, 2018Amendment$2,927,766$456,374vs May 7, 201828SEC filing
May 7, 2018Initial$2,471,392No comparison26SEC filing
Jan 3, 2018Initial$310,000No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-415718

Source: Form D, filed Oct 5, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Molly Bonakdarpour Director
Sean Boyd Promoter
Tom Brook Executive
Jonathan Bush Director
Mark D. Frank Director, Executive
Corley Hughes Executive
Curt Roberts Director
Eric Roza Director
Kent Thiry Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1738 Wynkoop Street Suite 303
Denver, CO, 80202